Skip to content
Screener

ADC Therapeutics ADCT Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Revenue$23.1MBeat by $757.8K
EPS-$0.04Beat by $0.28
Revenue estimate$22.3M
EPS estimate-$0.32

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$18.4M
EPS estimate-$0.21

FAQ

When did ADC Therapeutics report Q4 2025 earnings?
ADC Therapeutics (ADCT) reported Q4 2025 earnings on March 10, 2026 before market open.
What were ADC Therapeutics's Q4 2025 revenue and EPS?
ADC Therapeutics reported revenue of $23.1M and eps of $-0.04 for Q4 2025.
Did ADC Therapeutics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $22.3M by $757.8K. EPS beat the consensus estimate of $-0.32 by $0.28.
How did ADC Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 36.4% from $16.9M a year earlier and eps grew 86.2% from $-0.29.
Where can I find ADC Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-016238) and the 10-K periodic report (0001628280-26-016491) directly on SEC EDGAR. The filing index links above go to sec.gov.